SERT

The serotonin transporter (SERT) is a protein embedded in the membrane of serotonin-releasing neurons that pulls serotonin out of the synaptic cleft and back into the cell. This process — called reuptake — is the primary way serotonin signalling is switched off after a neuron fires.

SERT sits at the centre of how a wide range of drugs produce their effects. Blocking it or co-opting it changes how long serotonin remains active in the synapse, and by how much, making it one of the most pharmacologically significant proteins in the brain.

How it works · its role

SERT works as a molecular pump. After serotonin is released into the synaptic cleft, SERT binds the molecule and, driven by sodium gradients across the cell membrane, shuttles it back into the presynaptic neuron. Once inside, serotonin can be repackaged for future release or broken down by enzymes.

The transporter can be inhibited — physically blocked so serotonin cannot re-enter — or, under certain conditions, driven in reverse, actively pumping serotonin out of the neuron rather than in. These two modes of interaction are pharmacologically distinct and produce meaningfully different effects.

Relevance to substances & effects

The most familiar drugs acting on SERT are SSRIs (selective serotonin reuptake inhibitors) such as fluoxetine and sertraline. By blocking the transporter, they allow serotonin to linger in the synapse longer. The gradual accumulation of synaptic serotonin is thought to underlie their antidepressant and anxiolytic effects, though the full picture involves downstream receptor adaptations that develop over weeks.

SNRIs and tricyclic antidepressants also inhibit SERT, alongside other monoamine transporters.

MDMA takes a different route: it enters the presynaptic neuron via SERT and causes the transporter to run in reverse, flooding the synapse with serotonin rapidly and in large amounts. This reversal mechanism — rather than simple blockade — is thought to produce MDMA's characteristic emotional warmth and sense of closeness with others, and explains why its acute serotonin release is far more intense than that of an SSRI.

Cocaine and some other stimulants inhibit SERT as part of a broader monoamine blockade, though their primary subjective effects are driven more by DAT inhibition.

Clinical · risk note

Because SERT governs serotonin clearance, inhibiting it raises synaptic serotonin. Combining drugs that block SERT with substances that release serotonin, or with MAOIs that prevent its enzymatic breakdown, can push serotonin activity to dangerous levels — a central mechanism behind serotonin syndrome.

The interaction is not limited to recreational use: an SSRI taken alongside MDMA, or an MAOI taken alongside almost any serotonergic drug, carries serious risk. Knowing which substances act on SERT is part of understanding why certain combinations are flagged throughout the encyclopedia.